ZEPP HEALTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.853 USD | +1.55% |
|
+2.28% | -39.93% |
| Mar. 19 | Tranche Update on Zepp Health Corporation's Equity Buyback Plan announced on November 16, 2021. | CI |
| Mar. 19 | Transcript : Zepp Health Corporation, Q4 2023 Earnings Call, Mar 18, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,129 | 4,790 | 2,019 | 622.6 | 615.2 | 370.7 | - |
| Enterprise Value (EV) 1 | 5,129 | 4,790 | 2,019 | 622.6 | 615.2 | 370.7 | 370.7 |
| P/E ratio | 9.44 x | 21.9 x | 15.3 x | - | -2.93 x | -11.4 x | -13.3 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.88 x | 0.74 x | 0.32 x | 0.15 x | 0.25 x | 0.16 x | 0.14 x |
| EV / Revenue | 0.88 x | 0.74 x | 0.32 x | 0.15 x | 0.25 x | 0.16 x | 0.14 x |
| EV / EBITDA | 8.22 x | 23.8 x | 13.8 x | -1.77 x | - | 7.18 x | 2.38 x |
| EV / FCF | 13 x | 65 x | - | - | - | -4.66 x | -12.3 x |
| FCF Yield | 7.68% | 1.54% | - | - | - | -21.4% | -8.16% |
| Price to Book | 2.17 x | 1.84 x | 0.73 x | 0.23 x | - | - | - |
| Nbr of stocks (in thousands) | 61,291 | 61,950 | 62,954 | 62,256 | 61,038 | 59,980 | - |
| Reference price 2 | 12.02 | 11.85 | 5.050 | 1.450 | 1.420 | 0.8530 | 0.8530 |
| Announcement Date | 3/13/20 | 3/15/21 | 3/17/22 | 3/21/23 | 3/18/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 5,812 | 6,433 | 6,250 | 4,143 | 2,495 | 2,302 | 2,729 |
| EBITDA 1 | 623.7 | 201.3 | 145.8 | -351.6 | - | 51.61 | 155.5 |
| EBIT 1 | 606.5 | 174.2 | 93.94 | -410.2 | -147.4 | 16.09 | 115.2 |
| Operating Margin | 10.43% | 2.71% | 1.5% | -9.9% | -5.91% | 0.7% | 4.22% |
| Earnings before Tax (EBT) 1 | 652.4 | 265.6 | 106.7 | -372.5 | - | -155 | -132.3 |
| Net income 1 | 572.7 | 228.8 | 137.8 | - | -212.1 | -131.5 | -112.2 |
| Net margin | 9.85% | 3.56% | 2.2% | - | -8.5% | -5.71% | -4.11% |
| EPS 2 | 1.273 | 0.5399 | 0.3293 | - | -0.4848 | -0.0750 | -0.0640 |
| Free Cash Flow 1 | 393.7 | 73.75 | - | - | - | -79.52 | -30.26 |
| FCF margin | 6.77% | 1.15% | - | - | - | -3.46% | -1.11% |
| FCF Conversion (EBITDA) | 63.13% | 36.63% | - | - | - | - | - |
| FCF Conversion (Net income) | 68.74% | 32.24% | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 3/13/20 | 3/15/21 | 3/17/22 | 3/21/23 | 3/18/24 | - | - |
1CNY in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,606 | 1,662 | 757 | 1,108 | 1,206 | 1,072 | 645.2 | 599.7 | 328.6 | 514.8 | 732.2 | 818.5 |
| EBITDA 1 | 69.26 | - | - | -97.63 | -60.29 | - | - | - | -76.92 | -5.664 | 67.16 | 98.74 |
| EBIT 1 | 62.48 | 10.07 | -155.4 | -110.6 | -73.26 | -70.95 | -150.9 | 17.38 | -61.92 | 9.336 | 82.16 | 113.7 |
| Operating Margin | 3.89% | 0.61% | -20.53% | -9.98% | -6.08% | -6.62% | -23.39% | 2.9% | -18.84% | 1.81% | 11.22% | 13.9% |
| Earnings before Tax (EBT) | - | - | -109.1 | - | -54.23 | -77.54 | -158.7 | - | - | - | - | - |
| Net income | - | - | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/16/21 | 3/17/22 | 5/24/22 | 8/25/22 | 11/21/22 | 3/21/23 | 5/23/23 | 3/18/24 | - | - | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 394 | 73.7 | - | - | - | -79.5 | -30.3 |
| ROE (net income / shareholders' equity) | 26.6% | 8.75% | 7.82% | -8.55% | -5.9% | 5.18% | 11.1% |
| ROA (Net income/ Total Assets) | 13.6% | 4.13% | - | - | - | - | - |
| Assets 1 | 4,217 | 5,539 | - | - | - | - | - |
| Book Value Per Share | 5.530 | 6.450 | 6.960 | 6.320 | - | - | - |
| Cash Flow per Share | 0.9500 | - | -0.1300 | -1.860 | - | - | - |
| Capex 1 | 34.3 | 83.6 | - | - | - | 50 | 50 |
| Capex / Sales | 0.59% | 1.3% | - | - | - | 2.17% | 1.83% |
| Announcement Date | 3/13/20 | 3/15/21 | 3/17/22 | 3/21/23 | 3/18/24 | - | - |
1CNY in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.853
USD
Average target price
3.93
USD
Spread / Average Target
+360.73%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -39.93% | 51.16M | |
| -2.29% | 371B | |
| +22.71% | 1.95B | |
| -18.03% | 1.07B | |
| +66.81% | 831M | |
| +9.13% | 803M | |
| -11.48% | 763M | |
| +44.37% | 670M | |
| -29.73% | 358M | |
| -10.21% | 287M |
- Stock Market
- Equities
- ZEPP Stock
- Financials Zepp Health Corporation
